Related Experiment Video
Updated: Mar 1, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Cardiogenic Shock in Women
Vijay Kunadian1, Louise Coats2, Annapoorna S Kini3
1Institute of Cellular Medicine, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK; Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne Hospitals, NHS Foundation Trust, Newcastle upon Tyne, UK.
Insights
Cardiogenic shock (CS) is a severe condition where the heart cannot pump enough blood, leading to tissue hypoxia. Women with ST-elevation myocardial infarction (MI) face higher CS risk, necessitating targeted research and treatment strategies.
Area of Science:
- Cardiology
- Critical Care Medicine
Background:
- Cardiogenic shock (CS) is a life-threatening condition characterized by inadequate cardiac output and tissue hypoxia despite sufficient intravascular volume.
- It is the leading cause of mortality among hospitalized patients with myocardial infarction (MI).
- Women exhibit increased susceptibility to CS, particularly in the context of ST-elevation MI (STEMI).
Purpose of the Study:
- To examine the prevalence, causes, pathophysiology, and therapeutic strategies for cardiogenic shock specifically in women.
- To highlight the unique aspects of CS in female patients compared to the general population.
Main Methods:
- Review of existing literature on cardiogenic shock in women.
- Analysis of epidemiological data and clinical outcomes.
- Examination of pathophysiological mechanisms and treatment modalities.
Main Results:
- Women are more prone to developing CS after MI than men.
- Early revascularization and mechanical support have improved short-term survival but long-term prognosis remains challenging.
- Specific factors contributing to CS in women require further investigation.
Conclusions:
- Cardiogenic shock in women, especially post-MI, presents distinct challenges and requires tailored approaches.
- Further research is crucial to understand and mitigate the higher risk and poorer outcomes observed in women.
- Optimizing therapeutic options for female CS patients is essential for improving survival and quality of life.
Abstract:
Cardiogenic shock (CS) describes the physiologic state in which reduced cardiac output and resultant tissue hypoxia occur in the presence of adequate intravascular volume. Among patients hospitalized with myocardial infarction (MI), CS is the foremost cause of death. Women are more susceptible to CS than men in the setting of ST segment increase MI. Introduction of early revascularization strategies and mechanical ventricular support have seen a decrease in short-term mortality from CS. However, the prognosis following CS remains poor. This article examines the prevalence, causes, pathophysiology, and therapeutic options for CS among women.
Related Concept Videos
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Introduction Cardiac Emergencies
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy

